Abstract
Several short-lived accelerator-produced radionuclides for medical applications have been routinely produced over the last few years in Manchester, namely123I,81Rb−81mKr,111In,206Bi and191Pt. Nuclear reactions employed, target preparation and the radiochemical separation procedures used are briefly discussed.
Similar content being viewed by others
References
D. J. SILVESTER, J. SUGDEN, I. A. WATSON, Radiochem. Radioanal. Letters, 2 (1969) 17.
B. ROSENBERG, L. VAN CAMP, J. E. TROSKO, V. H. MANSOUR, Nature (London), 222 (1969) 385.
W. WOLF, R. C. MANAKA, F. K. V. LEH, Clin. Haematol. Oncology, (1977) 741.
W. WOLF, R. C. MANAKA, R. B. INGALLS, Radiopharmaceuticals in Clinical Pharmacology:195mPt-cis-dichlorodiammine platinum (11) in Radiopharmaceuticals and Labelled Compounds, Vol. II, IAEA, Vienna, 1973, p. 205.
R. C. MANAKA, W. WOLF, J. Nucl. Med., 19 (1978) 732.
P. H. S. SMITH, D. M. TAYLOR, J. Nucl. Med., 15 (1974) 349.
E. RENSHAW, A. J. THOMSON, J. Bacteriol., 94 (1967) 1915.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sharma, H.L., Smith, A.G. The short-lived radioisotope production program at manchester. J. Radioanal. Chem. 64, 249–255 (1981). https://doi.org/10.1007/BF02518355
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02518355